Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands.
Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands.
Radiother Oncol. 2021 Apr;157:182-187. doi: 10.1016/j.radonc.2021.01.026. Epub 2021 Feb 3.
Radiotherapy in the head and neck area may cause vascular damage to the carotid arteries, increasing the risk of anterior circulation ischaemic cerebrovascular events (ICVEs). However, limited data exists on the relationship between radiation dose to the carotid arteries and risk of ICVE. The purpose of this study was therefore to determine the relationship between radiation dose to the carotid arteries and anterior circulation ICVE risk.
A retrospective analysis of a prospective study cohort of 750 head and neck cancer patients treated with definitive (chemo)radiotherapy was performed. Carotid arteries were delineated, and dose-volume parameters of the treatment plans were calculated. ICVEs were scored prospectively and checked retrospectively by analysing all patient records. Cox proportional hazards analysis was performed to analyse the dose-effect relationships.
The median follow-up period was 3.4 years, 27 patients experienced an ICVE and the 5-year cumulative risk was 4.6%. ICVE risk was significantly associated with dose to the carotid arteries. Multivariable analysis showed that the absolute volume (cm) of the carotid arteries that received at least a radiation dose of 10 Gy was the most important prognostic factor for ICVE (HR = 1.11, AUC = 0.68, p < 0.001).
This is the first large prospective cohort study that demonstrates an independent dose-effect relationship between radiation dose to the carotid arteries and the risk of ICVE. These findings may be used to identify patients at risk for ICVE after radiotherapy who may benefit from primary or secondary preventive measures.
头颈部放射治疗可能会对颈动脉造成血管损伤,增加前循环缺血性脑血管事件(ICVE)的风险。然而,关于颈动脉受照剂量与 ICVE 风险之间的关系,目前仅有有限的数据。因此,本研究旨在确定颈动脉受照剂量与前循环 ICVE 风险之间的关系。
对 750 例接受根治性(放化疗)治疗的头颈部癌症患者的前瞻性研究队列进行回顾性分析。对颈动脉进行描绘,并计算治疗计划的剂量-体积参数。前瞻性地对 ICVE 进行评分,并通过分析所有患者的记录进行回顾性检查。采用 Cox 比例风险分析来分析剂量-效应关系。
中位随访时间为 3.4 年,27 例患者发生 ICVE,5 年累积风险为 4.6%。ICVE 风险与颈动脉受照剂量显著相关。多变量分析显示,接受至少 10 Gy 剂量照射的颈动脉绝对体积(cm)是 ICVE 的最重要预后因素(HR=1.11,AUC=0.68,p<0.001)。
这是第一项表明颈动脉受照剂量与 ICVE 风险之间存在独立剂量-效应关系的大型前瞻性队列研究。这些发现可用于识别放射治疗后发生 ICVE 风险的患者,这些患者可能受益于一级或二级预防措施。